
The Yamuna Krishnan Lab and Paschalis Kratsios Lab show that by exploiting either endogenous or synthetic receptor-ligand interactions and by leveraging the biological barriers presented by organisms, they can target extraneously introduced DNA nanodevices to specific cell types in C. elegans, with sub-cellular precision.